Adisseo reports strong Q1 performanceThursday, April 26, 2018
Jean-Marc Dublanc, CEO of Adisseo, said: "We are satisfied about the 2018 Q1 results which are in line with our expectation. Despite the suffering of some headwinds, such as FX or increase of raw materials cost, we successfully maintained our solid profit margin, thanks to our well balanced operation management, one-off contribution from Vitamin business and confirmed innovation capability. Our new specialty product Rovabio Advance Phy was introduced in the first quarter and is receiving very positive response from our customers. We would expect the Rovabio Advance Phy and other new products in pipeline together with Nutriad integration to make an important contribution in 2018. We firmly believe that innovation is a key engine for sustainable growth."